Department of Surgery

Projects

Projects per year 2007 2013 2014 2016 2017 2018 2020 2042

• 8 Active
• 56 Finished

Projects per year

Search results

• Active

  Studies of a new checkpoint regulator in the control of intestinal inflammation

  Zhang, Z. & Li, X. C.

  6/7/21 → 5/31/26

  Project: Federal Funding Agencies

• A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable Hepatocellular Carcinoma Patients

  Ghobrial, R. M., Abdelrahim, M. & Kodali, S.

  4/1/21 → 3/31/26

  Project: Federal Funding Agencies

• Transforming triple negative breast cancer treatment through intratumoral immunotherapy via nanofluidic drug eluting seed

  Grattoni, A.

  8/1/20 → 7/31/24

  Project: Federal Funding Agencies

• PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED, PARALLEL-GROUP, STUDY OF AB103 AS COMPARED TO PLACEBO IN PATIENTS WITH NECROTIZING SOFT TISSUE INFECTIONS (NSTI)

  Dhala, A., Martinez, S., Mobley, C. M. & Ochoa, R. A.

  6/20/17 → 6/19/42

  Project: Federal Funding Agencies

• A RANDOMIZED PHASE III DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OFASPIRIN AS ADJUVANT THERAPY FOR HER2 NEGATIVE BREAST CANCER: THE ABCTRIAL

  Arentz, C., Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.

  12/8/16 → 12/7/41

  Project: Non Profit

• Control of dysfunctional Tregs

  Li, X. C. & Xiao, J.

  2/1/14 → 1/31/26

  Project: Federal Funding Agencies

• NanoGland for Breast Cancer Prevention

  Grattoni, A.

  Nancy Owens Memorial Foundation

  2/1/14 → 12/31/24

  Project: Non Profit

• A PHASE III TRIAL EVALUATING THE ADDITION OF TRASTUZUMAB TO TRIMODALITY TREATMENT OF HER2-OVEREXPRESSING ESOPHAGEAL ADENOCARCINOMA

  Butler, E. B., Kim, M. P. & Teh, B. S.

  University of Michigan

  7/24/13 → 7/23/38

  Project: Non Profit